Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity

Plasticity is a hallmark of aggressive tumors, including glioblastoma (GBM), enabling tumor cells and the tumor microenvironment (TME) to adapt to diverse niches and evade treatment. Here, we discuss how innate and adaptive immune players cooperate in time and space to create an immunosuppressive TM...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Moreno-Sanchez, Pilar M. (VerfasserIn) , Rezaeipour, Mahsa (VerfasserIn) , Inderberg, Else Marit (VerfasserIn) , Platten, Michael (VerfasserIn) , Golebiewska, Anna (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January 2026
In: Nature cancer
Year: 2026, Jahrgang: 7, Pages: 29-42
ISSN:2662-1347
DOI:10.1038/s43018-025-01097-9
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s43018-025-01097-9
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s43018-025-01097-9
Volltext
Verfasserangaben:Pilar M. Moreno-Sanchez, Mahsa Rezaeipour, Else Marit Inderberg, Michael Platten & Anna Golebiewska
Beschreibung
Zusammenfassung:Plasticity is a hallmark of aggressive tumors, including glioblastoma (GBM), enabling tumor cells and the tumor microenvironment (TME) to adapt to diverse niches and evade treatment. Here, we discuss how innate and adaptive immune players cooperate in time and space to create an immunosuppressive TME that supports GBM growth and confers resistance to conventional treatments and immunotherapies. We highlight how therapeutic interventions reshape the TME, underscoring the need for targeted approaches to overcome resistance. We introduce the concepts of local TME priming and TME rewiring as necessary foundations for achieving more effective and durable clinical responses in the future.
Beschreibung:Online veröffentlicht: 8. Januar 2026
Gesehen am 10.02.2026
Beschreibung:Online Resource
ISSN:2662-1347
DOI:10.1038/s43018-025-01097-9